| Literature DB >> 12047041 |
Tomohiko Okuda1, Toshiki Sumiya, Ken-ichi Mizutani, Naomi Tago, Toshiyuki Miyata, Tadashi Tanabe, Hisao Kato, Tomohiro Katsuya, Jitsuo Higaki, Toshio Ogihara, Yasuyuki Tsujita, Naoharu Iwai, Ken-ichi Muzutani, Hiroshi Kato.
Abstract
We identified genes that were differentially expressed between spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) using cDNA microarray analysis, and analyzed the correlation between these genes and hypertension. Twenty four genes were found to be up-regulated and 20 were down-regulated in SHR. We selected 11 genes (6 up-regulated genes: SAH, Hsp70, MCT1, RBP, IDI1, Prion; and 5 down-regulated genes: Thrombin, Dyn, SOD3, Ela1, Gst Y(b)) and subjected them to an F2 cosegregation analysis. One hundred five F2 rats were obtained from the same strains used for microarray analysis, and blood pressure was measured directly with a catheter implanted in the femoral artery. The genotypes of monocarboxylate transporter 1 and glutathione S-transferase Y(b) subunit significantly affected diastolic blood pressure in F2 rats, and these two genes are located near each other on chromosome 2. However, quantitative trait loci (QTL) analysis in this region revealed that the QTL for diastolic blood pressure were from these two genes. Antihypertensive treatment with either enalapril or hydralazine only affected the expression level of Hsp70, which was up-regulated by hydralazine, probably through compensatory sympathetic activation. We were unable to associate the other 10 genes with hypertension in SHR. Based on these results, the identification of differentially expressed genes may not be an efficient method for selecting candidate genes for hypertension in the SHR-WKY system.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12047041 DOI: 10.1291/hypres.25.249
Source DB: PubMed Journal: Hypertens Res ISSN: 0916-9636 Impact factor: 3.872